Title: HOUSE BILL 1004
Official Title: HOUSE BILL 1004
Number of Sections: 1
Source: versions - First - Public Health - Alzheimer's Disease and Related Dementias - Information on Prevalence and Treatment
Media Type: application/pdf
Strikethrough Detection: 3 sections found

================================================================================

Section 1:
J1 5lr2242
CF SB 748
By: Delegate Martinez
Introduced and read first time: January 31, 2025
Assigned to: Health and Government Operations
A BILL ENTITLED
1 AN ACT concerning
2 Public Health – Alzheimer’s Disease and Related Dementias – Information on
3 Prevalence and Treatment
4 FOR the purpose of requiring the Maryland Department of Health, in partnership with
5 certain entities, to incorporate information regarding treatments approved by the
6 Food and Drug Administration for Alzheimer’s disease and related dementias and to
7 increase understanding and awareness of treatment of Alzheimer’s disease and
8 related dementias into relevant public health outreach programs administered by
9 the Department; requiring the Department to establish and maintain a website that
10 includes certain information on the prevalence and hospitalization rate of
11 Alzheimer’s disease and related dementias; and generally related to Alzheimer’s
12 disease and related dementias.
13 BY repealing and reenacting, with amendments,
14 Article – Health – General
15 Section 18–110
16 Annotated Code of Maryland
17 (2023 Replacement Volume and 2024 Supplement)
18 BY adding to
19 Article – Health – General
20 Section 18–111
21 Annotated Code of Maryland
22 (2023 Replacement Volume and 2024 Supplement)
23 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
24 That the Laws of Maryland read as follows:
25 Article – Health – General
26 18–110.
EXPLANATION: CAPITALS INDICATE MATTER ADDED TO EXISTING LAW.
[Brackets] indicate matter deleted from exist in g l aw . *hb1004*
2 HOUSE BILL 1004
1 The Department, in partnership with the Department of Aging, the Virginia I. Jones
2 Alzheimer’s Disease and Related Disorders Council, and the Greater Maryland Chapter of
3 the Alzheimer’s Association, shall incorporate information into relevant public health
4 outreach programs administered by the Department to:
5 (1) Educate health care providers regarding:
6 (i) The importance of early detection and timely diagnosis of
7 cognitive impairment;
8 (ii) Validated assessment tools for the detection and diagnosis of
9 cognitive impairment;
10 (iii) The value of a Medicare annual wellness visit or other annual
11 physical for an individual at least 65 years old for cognitive health; [and]
12 (iv) The Medicare care planning billing code for individuals with
13 cognitive impairment; and
14 (V) TREATMENTS APPROVED BY THE FOOD AND DRUG
15 ADMINISTRATION FOR ALZHEIMER’S DISEASE AND RELATED DEMENTIAS; AND
16 (2) Increase understanding and awareness of:
17 (i) The early warning signs of Alzheimer’s disease and [other types
18 of dementia] RELATED DEMENTIAS;
19 (ii) The value of early detection [and], diagnosis, AND TREATMENT
20 of Alzheimer’s disease and [other types of dementia] RELATED DEMENTIAS; and
21 (iii) How to reduce the risk of cognitive decline, particularly among
22 individuals in Black and Latino communities who are at greater risk of developing
23 Alzheimer’s disease and [other types of dementia] RELATED DEMENTIAS.
24 18–111.
25 (A) THE DEPARTMENT, IN COLLABORATION WITH THE STATE–DESIGNATED
26 HEALTH INFORMATION EXCHANGE, SHALL ESTABLISH AND MAINTAIN A PUBLICLY
27 ACCESSIBLE WEBSITE THAT INCLUDES IN A DOWNLOADABLE FORMAT THE
28 FOLLOWING INFORMATION:
29 (1) THE PREVALENCE OF ALZHEIMER’S DISEASE AND RELATED
30 DEMENTIAS IN THE STATE;
HOUSE BILL 1004 3
1 (2) THE HOSPITALIZATION RATE RELATED TO ALZHEIMER’S DISEASE
2 AND RELATED DEMENTIAS; AND
3 (3) TO THE EXTENT POSSIBLE, THE PREVALENCE AND
4 HOSPITALIZATION RATE OF ALZHEIMER’S DISEASE AND RELATED DEMENTIAS
5 DISAGGREGATED BASED ON:
6 (I) AGE, INCLUDING AGE OF DIAGNOSIS;
7 (II) SEX;
8 (III) RACE;
9 (IV) ETHNICITY; AND
10 (V) NUMBER OF CASES BY COUNTY.
11 (B) THE WEBSITE REQUIRED UNDER SUBSECTION (A) OF THIS SECTION
12 SHALL:
13 (1) INCLUDE THE DATA AVAILABLE FOR THE IMMEDIATELY
14 PRECEDING 5–YEAR PERIOD ENDING SEPTEMBER 30, 2025; AND
15 (2) BE UPDATED ON OR BEFORE JANUARY 1 EACH YEAR, BEGINNING
16 IN 2027, TO INCLUDE ANY NEWLY AVAILABLE DATA.
17 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect
18 October 1, 2025.
[DELETED: :CA      5   C A P P F c F i u a a o t o A d a r t i c i o t p a h r o A d a r d a g r t A d B  A S  A  ( B  A S  A  (  S T A 1]
[DELETED:  H   T A t A A s i i i r p h o   ( E    ( T i o e d a t d o c    ( V a t f t d a d o c    ( T p a]    ( T M c p b c f i w c  () TFR A B T O A RA’; LRSS    ( I    ( T o oa;    ( T ad s], o oa;    ( H i i B a L c w a a g r o d A oa.() TD,SH ET  TEDE  W T I I A D F T ( TA P O LRS D A R T;]
[DELETED: H 3 ( TA LRSS  ( T T E PE T P A R O LRS D A R D  () A,;GE   () S;IE  () R;IA  () E;VTY   () N.U() T(H W R U S A O T S (  T D A F T I Y E   –S3,2; ( BJ1 A  R   ,.  S A B I F E T t A s t e O]


================================================================================

Raw Text:
HOUSE BILL 1004
J1 5lr2242
CF SB 748
By: Delegate Martinez
Introduced and read first time: January 31, 2025
Assigned to: Health and Government Operations
A BILL ENTITLED
1 AN ACT concerning
2 Public Health – Alzheimer’s Disease and Related Dementias – Information on
3 Prevalence and Treatment
4 FOR the purpose of requiring the Maryland Department of Health, in partnership with
5 certain entities, to incorporate information regarding treatments approved by the
6 Food and Drug Administration for Alzheimer’s disease and related dementias and to
7 increase understanding and awareness of treatment of Alzheimer’s disease and
8 related dementias into relevant public health outreach programs administered by
9 the Department; requiring the Department to establish and maintain a website that
10 includes certain information on the prevalence and hospitalization rate of
11 Alzheimer’s disease and related dementias; and generally related to Alzheimer’s
12 disease and related dementias.
13 BY repealing and reenacting, with amendments,
14 Article – Health – General
15 Section 18–110
16 Annotated Code of Maryland
17 (2023 Replacement Volume and 2024 Supplement)
18 BY adding to
19 Article – Health – General
20 Section 18–111
21 Annotated Code of Maryland
22 (2023 Replacement Volume and 2024 Supplement)
23 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
24 That the Laws of Maryland read as follows:
25 Article – Health – General
26 18–110.
EXPLANATION: CAPITALS INDICATE MATTER ADDED TO EXISTING LAW.
[Brackets] indicate matter deleted from exist in g l aw . *hb1004*

2 HOUSE BILL 1004
1 The Department, in partnership with the Department of Aging, the Virginia I. Jones
2 Alzheimer’s Disease and Related Disorders Council, and the Greater Maryland Chapter of
3 the Alzheimer’s Association, shall incorporate information into relevant public health
4 outreach programs administered by the Department to:
5 (1) Educate health care providers regarding:
6 (i) The importance of early detection and timely diagnosis of
7 cognitive impairment;
8 (ii) Validated assessment tools for the detection and diagnosis of
9 cognitive impairment;
10 (iii) The value of a Medicare annual wellness visit or other annual
11 physical for an individual at least 65 years old for cognitive health; [and]
12 (iv) The Medicare care planning billing code for individuals with
13 cognitive impairment; and
14 (V) TREATMENTS APPROVED BY THE FOOD AND DRUG
15 ADMINISTRATION FOR ALZHEIMER’S DISEASE AND RELATED DEMENTIAS; AND
16 (2) Increase understanding and awareness of:
17 (i) The early warning signs of Alzheimer’s disease and [other types
18 of dementia] RELATED DEMENTIAS;
19 (ii) The value of early detection [and], diagnosis, AND TREATMENT
20 of Alzheimer’s disease and [other types of dementia] RELATED DEMENTIAS; and
21 (iii) How to reduce the risk of cognitive decline, particularly among
22 individuals in Black and Latino communities who are at greater risk of developing
23 Alzheimer’s disease and [other types of dementia] RELATED DEMENTIAS.
24 18–111.
25 (A) THE DEPARTMENT, IN COLLABORATION WITH THE STATE–DESIGNATED
26 HEALTH INFORMATION EXCHANGE, SHALL ESTABLISH AND MAINTAIN A PUBLICLY
27 ACCESSIBLE WEBSITE THAT INCLUDES IN A DOWNLOADABLE FORMAT THE
28 FOLLOWING INFORMATION:
29 (1) THE PREVALENCE OF ALZHEIMER’S DISEASE AND RELATED
30 DEMENTIAS IN THE STATE;

HOUSE BILL 1004 3
1 (2) THE HOSPITALIZATION RATE RELATED TO ALZHEIMER’S DISEASE
2 AND RELATED DEMENTIAS; AND
3 (3) TO THE EXTENT POSSIBLE, THE PREVALENCE AND
4 HOSPITALIZATION RATE OF ALZHEIMER’S DISEASE AND RELATED DEMENTIAS
5 DISAGGREGATED BASED ON:
6 (I) AGE, INCLUDING AGE OF DIAGNOSIS;
7 (II) SEX;
8 (III) RACE;
9 (IV) ETHNICITY; AND
10 (V) NUMBER OF CASES BY COUNTY.
11 (B) THE WEBSITE REQUIRED UNDER SUBSECTION (A) OF THIS SECTION
12 SHALL:
13 (1) INCLUDE THE DATA AVAILABLE FOR THE IMMEDIATELY
14 PRECEDING 5–YEAR PERIOD ENDING SEPTEMBER 30, 2025; AND
15 (2) BE UPDATED ON OR BEFORE JANUARY 1 EACH YEAR, BEGINNING
16 IN 2027, TO INCLUDE ANY NEWLY AVAILABLE DATA.
17 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect
18 October 1, 2025.

[DELETED: :CA      5   C A P P F c F i u a a o t o A d a r t i c i o t p a h r o A d a r d a g r t A d B  A S  A  ( B  A S  A  (  S T A 1]
[DELETED:  H   T A t A A s i i i r p h o   ( E    ( T i o e d a t d o c    ( V a t f t d a d o c    ( T p a]    ( T M c p b c f i w c  () TFR A B T O A RA’; LRSS    ( I    ( T o oa;    ( T ad s], o oa;    ( H i i B a L c w a a g r o d A oa.() TD,SH ET  TEDE  W T I I A D F T ( TA P O LRS D A R T;]
[DELETED: H 3 ( TA LRSS  ( T T E PE T P A R O LRS D A R D  () A,;GE   () S;IE  () R;IA  () E;VTY   () N.U() T(H W R U S A O T S (  T D A F T I Y E   –S3,2; ( BJ1 A  R   ,.  S A B I F E T t A s t e O]